Exomind (rTMS) Treatment

Exomind for Smoking Cessation

Exomind (rTMS) for smoking cessation — an FDA-cleared application, using a specific protocol to help reduce nicotine cravings and support quitting.

Exomind for Smoking Cessation

rTMS received FDA clearance specifically as an aid for smoking cessation in 2020, using a protocol designed to reduce nicotine cravings by targeting brain reward circuitry, making this one of the more established addiction-related applications of rTMS beyond depression.

Dr. Muhammad Shoaib Zafar offers Exomind treatment for smoking cessation as part of a comprehensive quit-smoking plan, combined with behavioural support.

How This Differs From the Depression Protocol

The smoking cessation protocol uses a specific stimulation pattern and target designed to reduce cue-triggered cravings, distinct from the standard depression protocol, reflecting the specific brain reward circuitry involved in nicotine addiction.

Clinical Evidence

Clinical trials supporting FDA clearance demonstrated that this rTMS protocol, combined with standard smoking cessation counselling, produced higher quit rates than counselling alone, supporting its use as an effective adjunct treatment.

Combining With Other Approaches

rTMS for smoking cessation is most effective when combined with behavioural counselling and, where appropriate, other evidence-based aids such as nicotine replacement therapy or cessation medication, rather than used in isolation.

Frequently Asked Questions

Frequently Asked Questions

Is rTMS for smoking cessation FDA-cleared?

Yes, this specific application received FDA clearance in 2020, based on dedicated clinical trials.

Do I need to combine rTMS with other quit-smoking methods?

Yes, combining rTMS with behavioural counselling and, where appropriate, other evidence-based cessation aids produces the best results.

Expert Care

Dr. Muhammad Shoaib Zafar provides evidence-based Exomind treatment for smoking cessation as part of a comprehensive quit-smoking plan.

This page is provided for general educational purposes and does not replace an individual psychiatric assessment.

Common signs & symptoms

  • Persistent nicotine cravings
  • Difficulty quitting despite repeated attempts
  • Withdrawal symptoms when trying to stop smoking

Treatment approach

  • A structured course of rTMS using an FDA-cleared smoking cessation protocol
  • Combined with behavioural support and, where appropriate, nicotine replacement or medication
  • Individualised assessment of smoking history and prior quit attempts

Frequently asked questions

Is rTMS for smoking cessation FDA-cleared?

Yes, this specific application received FDA clearance in 2020, based on dedicated clinical trials.

Do I need to combine rTMS with other quit-smoking methods?

Yes, combining rTMS with behavioural counselling and, where appropriate, other evidence-based cessation aids produces the best results.